You are here

MICRONIX, INC.

Company Information
Address
MICRONIX, INC. 14950 GREYHOUND CT, STE 307
CARMEL, IN 46032
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: Yes



Award Charts




Award Listing

  1. Non-instrumented Device for Diabetic/Vascular Risk S

    Amount: $99,944.00

    DESCRIPTION (provided by applicant): More than half of the world's diabetics and individuals at risk for atherosclerosis due to high blood glucose and lipids (cholesterol, triglyceride) are undiagnose ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
  2. Novel Devices for Management of Toxic Alcohol Exposure

    Amount: $745,598.00

    DESCRIPTION (provided by applicant): The applicant organization proposes to develop ultra-miniaturized, minimally invasive test wand methods for quantification in whole blood specimens of methanol, fo ...

    SBIRPhase II2005Department of Health and Human Services National Institutes of Health
  3. Novel Solid State Diabetes Monitoring System

    Amount: $0.00

    DESCRIPTION (provided by applicant): The applicant organization proposes to develop an ultra-miniaturized, minimally invasive diabetes monitoring system for estimating concentrations of diabetes-r ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
  4. Novel Solid State Diabetes Monitoring System

    Amount: $652,257.00

    DESCRIPTION (provided by applicant): The applicant organization proposes to develop an ultra-miniaturized, minimally invasive diabetes monitoring system for estimating concentrations of diabetes-r ...

    SBIRPhase II2003Department of Health and Human Services National Institutes of Health
  5. CONSOLIDATED DIABETES SCREENING DEVICE

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Of the 120 million diabetics in the world, one half are undiagnosed and therefore deprived of the proven benefits of tight glucose control in curbing diabetes-rela ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  6. Novel Assay for Ethylene Glycol Toxicity

    Amount: $0.00

    DESCRIPTION: (Applicant's abstract) Poisoning from ethylene glycol is a potentially lethal medical emergency but can be treated effectively when recognized early. Conversely, ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
  7. Novel Assay for Ethylene Glycol Toxicity

    Amount: $382,201.00

    DESCRIPTION: (Applicant's abstract) Poisoning from ethylene glycol is a potentially lethal medical emergency but can be treated effectively when recognized early. Conversely, ...

    SBIRPhase II2001Department of Health and Human Services National Institutes of Health
  8. NOVEL SOLID STATE DIABETES MONITORING SYSTEM

    Amount: $100,000.00

    DESCRIPTION (Adapted from the Investigator's Abstract): Liver failure is a major cause of death in the U.S. There is a great need for a liver assist device for temporary support o ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
  9. N/A

    Amount: $100,000.00

    N/A

    SBIRPhase I2000Department of Health and Human Services National Institutes of Health
  10. N/A

    Amount: $729,645.00

    N/A

    SBIRPhase II1999Department of Health and Human Services
US Flag An Official Website of the United States Government